Evidence map›Paper›PMID 40400381›Full record

SynthesisActa otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale2025

Margins in major salivary gland surgery: clinical and pathological criteria for defining margins and their implications on the choice of multimodal therapies. A systematic review.

Marco de Vincentiis, Giulio Pagliuca, Valerio Margani, Vanessa Di Stefano, Giovanni Succo, Erika Crosetti, Cesare Piazza, Federica Zoccali, Diletta Angeletti, Andrea Gallo

Abstract readSystematic Review
In one paragraph

Synthesis in Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Survival and prognostic factors of parotid malignancies in Northern Italy: a multicentric study.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marco de VincentiisDepartment of Sensory Organs, "Sapienza" University of Rome, Rome, Italy.
Giulio PagliucaOtorhinolaryngology University Unit, "S.M. Goretti Hospital", Latina, Italy.
Valerio MarganiOtorhinolaryngology University Unit, "S.M. Goretti Hospital", Latina, Italy.
Vanessa Di StefanoDepartment of Sensory Organs, "Sapienza" University of Rome, Rome, Italy.
Giovanni SuccoOncology Department, University of Turin, Italy.
Erika CrosettiOtorhinolaryngology Department - Head Neck Cancer Unit, San Giovanni Bosco Hospital, Turin, Italy.
Cesare PiazzaUnit of Otorhinolaryngology - Head and Neck Surgery, ASST Spedali Civili Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, School of Medicine, University of Brescia, Brescia, Italy.
Federica ZoccaliDepartment of Sensory Organs, "Sapienza" University of Rome, Rome, Italy.
Diletta AngelettiDepartment of Sensory Organs, "Sapienza" University of Rome, Rome, Italy.
Andrea GalloDepartment of Sensory Organs, "Sapienza" University of Rome, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Major salivary gland malignancies (MSGM) are a rare and heterogeneous group of tumours accounting for 1-5% of all head and neck cancers. When feasible, surgical removal with negative margins is the preferred treatment, reserving adjuvant radiotherapy for adverse clinicopathological features such as high-grade, advanced-stage, extranodal extension, lympho-vascular invasion, perineural invasion, and positive margins. This systematic review aims to evaluate the current literature on the definition of negative and close margins for MSGM, their impact on loco-regional recurrence (LRR), disease-free (DFS), and overall survival (OS), and their implications in the choice of multimodal therapies. Methods: An online search of articles published between 2004 and 2024 was carried out using PubMed via a PICO search strategy for qualitative questions and written following the PRISMA statement guidelines. The following parameters were evaluated: definition of free and close margins, and their impact on local control. Results: The initial search yielded 158 articles. Following the application of inclusion and exclusion criteria, 30 full-text publications were reviewed. All studies were retrospective. A total of 15,985 patients who underwent surgery were considered. Margin involvement ranged widely among the studies from 14.3% to 65.4%. Five out of 30 studies reported no data about association between margins and LRR, DFS, and OS. Twenty of 25 studies reported a significant correlation between positive margins and oncological outcomes regardless of the histological types, while 5 focused on high-stage cancers or more aggressive histotypes and described no association between margin status and oncological outcomes. Nine of 30 studies described close margins in the absence of a univocal definition of threshold for close vs. negative margins. Most studies did not report a significant correlation between close margins and oncological outcomes. Conclusions: Surgical resection achieving negative margins is recommended for MSGM. Positive margin is widely considered an adverse clinicopathological feature and performing adjuvant radiotherapy has documented survival benefits. A consensus involving a definition of close margin is missing, although further treatment is not recommended, preferring a watch-and-wait approach in presence of close margins.

Indexed as

Margins of ExcisionSalivary Gland NeoplasmsCombined Modality TherapyHumanscancerclose marginssalivary glandssurgical marginssurvival

Identifiers

PMID40400381
PMCPMC12115411

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.